7NXZ | pdb_00007nxz

Synthetic glycoform of Human Interleukin 6

  • Classification: CYTOKINE
  • Organism(s): Homo sapiens
  • Mutation(s): No 

  • Deposited: 2021-03-19 Released: 2021-04-07 
  • Deposition Author(s): Weyand, M., Unverzagt, C.
  • Funding Organization(s): German Research Foundation (DFG)

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.253 (Depositor), 0.253 (DCC) 
  • R-Value Work: 
    0.206 (Depositor), 0.206 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7NXZ

This is version 1.3 of the entry. See complete history

Literature

Natural Glycoforms of Human Interleukin 6 Show Atypical Plasma Clearance.

Reif, A.Lam, K.Weidler, S.Lott, M.Boos, I.Lokau, J.Bretscher, C.Monnich, M.Perkams, L.Schmalzlein, M.Graf, C.Fischer, J.P.Lechner, C.Hallstein, K.Becker, S.Weyand, M.Steegborn, C.Schultheiss, G.Rose-John, S.Garbers, C.Unverzagt, C.

(2021) Angew Chem Int Ed Engl 60: 13380-13387

  • DOI: https://doi.org/10.1002/anie.202101496
  • Primary Citation Related Structures: 
    7NXZ

  • PubMed Abstract: 

    A library of glycoforms of human interleukin 6 (IL-6) comprising complex and mannosidic N-glycans was generated by semisynthesis. The three segments were connected by sequential native chemical ligation followed by two-step refolding. The central glycopeptide segments were assembled by pseudoproline-assisted Lansbury aspartylation and subsequent enzymatic elongation of complex N-glycans. Nine IL-6 glycoforms were synthesized, seven of which were evaluated for in vivo plasma clearance in rats and compared to non-glycosylated recombinant IL-6 from E. coli. Each IL-6 glycoform was tested in three animals and reproducibly showed individual serum clearances depending on the structure of the N-glycan. The clearance rates were atypical, since the 2,6-sialylated glycoforms of IL-6 cleared faster than the corresponding asialo IL-6 with terminal galactoses. Compared to non-glycosylated IL-6 the plasma clearance of IL-6 glycoforms was delayed in the presence of larger and multibranched N-glycans in most cases.


  • Organizational Affiliation
    • Bioorganic Chemistry, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.

Macromolecule Content 

  • Total Structure Weight: 20.82 kDa 
  • Atom Count: 1,327 
  • Modeled Residue Count: 159 
  • Deposited Residue Count: 183 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Interleukin-6A [auth AAA]183Homo sapiensMutation(s): 0 
UniProt & NIH Common Fund Data Resources
Find proteins for P05231 (Homo sapiens)
Explore P05231 
Go to UniProtKB:  P05231
PHAROS:  P05231
GTEx:  ENSG00000136244 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP05231
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
NLE
Query on NLE
A [auth AAA]L-PEPTIDE LINKINGC6 H13 N O2LEU

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.253 (Depositor), 0.253 (DCC) 
  • R-Value Work:  0.206 (Depositor), 0.206 (DCC) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 72.1α = 90
b = 129.02β = 90
c = 50.1γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
pointlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
German Research Foundation (DFG)GermanyDFG UN63/5-1 + SPPP1368

Revision History  (Full details and data files)

  • Version 1.0: 2021-04-07
    Type: Initial release
  • Version 1.1: 2021-06-09
    Changes: Database references
  • Version 1.2: 2024-01-31
    Changes: Data collection, Database references, Derived calculations, Refinement description
  • Version 1.3: 2024-10-23
    Changes: Structure summary